References
- WHO. Pneumococcal conjugate vaccine for childhood immunization – WHO position paper. Wkly Epidemiol. Rec.82(12), 93–104 (2007).
- Madhi SA, Klugman KP; Vaccine Trialist Group. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat. Med.10(8), 811–813 (2004).
- Talbot TR, Poehling KA, Hartert TV et al. Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. Am. J. Med.118(3), 285–291 (2005).
- McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin. Microbiol. Rev.19(3), 571–582 (2006).
- Madhi SA, Ludewick H, Kuwanda L et al. Pneumococcal coinfection with human metapneumovirus. J. Infect. Dis.193(9), 1236–1243 (2006).
- Stensballe LG, Hjuler T, Andersen A et al. Hospitalization for respiratory syncytial virus infection and invasive pneumococcal disease in Danish children aged <2 years: a population-based cohort study. Clin. Infect. Dis.46(8), 1165–1171 (2008).
- Klugman KP, Madhi SA. Pneumococcal vaccines and flu preparedness. Science316(5821), 49–50 (2007).
- Evers SM, Ament AJ, Colombo GL et al. Cost–effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries. Eur. J. Clin. Microbiol. Infect. Dis.26(8), 531–540 (2007).
- Grijalva CG, Nuorti JP, Arbogast PG, Martin SW, Edwards KM, Griffin MR. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet369(9568), 1179–1186 (2007).
- Tsai CJ, Griffin MR, Pekka Nuorti J, Grijalva CG. Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clin. Infect. Dis.46(11), 1664–1672 (2008).
- Grijalva CG, Griffin MR. Population-based impact of routine infant immunization with pneumococcal conjugate vaccine in the USA. Expert Rev. Vaccines7(1), 83–95 (2008).
- Levine OS, O’Brien KL, Knoll M et al. Pneumococcal vaccination in developing countries. Lancet367(9526), 1880–1882 (2006).
- Madhi SA, Levine OS, Hajjeh R, Mansoor OD, Cherian T. Vaccines to prevent pneumonia and improve child survival. Bull. World Health Organ.86(5), 365–372 (2008).
- Mandell LA, Wunderink RG, Anzueto A et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis.44(Suppl. 2), S27–S72 (2007).
- Hsu H, Shutt KA, Moore MR et al. Meningitis among adults and children in the era of the pneumococcal conjugate vaccine: an update from Active Bacterial Core surveillance (ABCs). Presented at: 6th International Symposium on Pneumococci and Pneumococcal Diseases. Reykjavik, Iceland, 9–12 June 2008 (Poster P3–P123).
- Schuchat A, Pilishvili T, Farley M et al. Near elimination of vaccine-type invasive pneumococcal disease in U.S. following conjugate vaccine implementation, 1998–2006. Presented at: 6th International Symposium on Pneumococci and Pneumococcal Diseases. Reykjavik, Iceland, 9–12 June 2008 (Poster P3–P132).
- Simell B, Grönholm S, Jaakkola E et al. Effect of ageing and gender on naturally acquired antibodies to pneumococcal polysaccharides and virulence-associated proteins. Presented at: 6th International Symposium on Pneumococci and Pneumococcal Diseases. Reykjavik, Iceland, 9–12 June 2008 (Poster P3–P004).
- Väkeväinen M, Vuorela A, Ekström N et al. Aging reduces phagocytic killing of Streptococcus pneumoniae by neutrophils. Presented at: 6th International Symposium on Pneumococci and Pneumococcal Diseases. Reykjavik, Iceland, 9–12 June 2008 (Poster P3–P006).